Page last updated: 2024-11-05

tranexamic acid and Diabetes Mellitus, Type 2

tranexamic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Tranexamic acid usage was associated with decreased blood loss."1.48Patients With Infected Total Hip Arthroplasty Undergoing 2-Stage Exchange Arthroplasty Experience Massive Blood Loss. ( Buckley, P; Goel, R; Parvizi, J; Sterbis, E, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goel, R1
Buckley, P1
Sterbis, E1
Parvizi, J1
Revollo, JY1
Cuffy, MC1
Witte, DP1
Paterno, F1
Alloway, RR1
Woodle, ES1

Other Studies

2 other studies available for tranexamic acid and Diabetes Mellitus, Type 2

ArticleYear
Patients With Infected Total Hip Arthroplasty Undergoing 2-Stage Exchange Arthroplasty Experience Massive Blood Loss.
    The Journal of arthroplasty, 2018, Volume: 33, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Blood Loss, S

2018
Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.
    Transplantation proceedings, 2015, Volume: 47, Issue:7

    Topics: Aged; Anemia, Hemolytic; Antifibrinolytic Agents; Diabetes Mellitus, Type 2; Disseminated Intravascu

2015